Issuer · CIK 0001819133

TNGX — Tango Therapeutics, Inc.

Recent filings

May 5, 2026·Form 4·Sell$548.9K
TNGX/Tango Therapeutics, Inc.
Crystal Adam · President, R&D
10conviction
May 5, 2026·Form 4·Other—
TNGX/Tango Therapeutics, Inc.
Gall Matthew · Chief Financial Officer
Mechanical filing
AI thesis skipped

← Back to all filings